← Ablatotech Vitals
GeneralSurgery EvidenceDigest

Antibiotics versus appendectomy for uncomplicated appendicitis

GeneralSurgery · EvidenceDigest

Reviewed by the Ablatotech Vitals editorial team
September 23, 2026 · Reviewer: dekema
Educational use only. This digest is AI-curated commentary reviewed by clinicians. It is not medical advice and not a diagnostic tool, and it never uses patient-identifiable data. Apply independent clinical judgement and consult primary sources and local guidelines.

For patients with uncomplicated appendicitis, antibiotics offer a viable alternative to appendectomy, with many patients successfully avoiding surgery. However, the risk of recurrence and the need for subsequent appendectomy remain considerations. Shared decision-making is crucia…

# EvidenceDigest: Antibiotics versus Appendectomy for Uncomplicated Appendicitis

Clinical bottom line

For patients with uncomplicated appendicitis, antibiotics offer a viable alternative to appendectomy, with many patients successfully avoiding surgery. However, the risk of recurrence and the need for subsequent appendectomy remain considerations. Shared decision-making is crucial to align treatment with patient preferences and clinical circumstances.

What the evidence shows

Recent studies have explored the efficacy of antibiotics as a primary treatment for uncomplicated appendicitis. The CODA trial (2020), a large randomized controlled trial, demonstrated that antibiotics were non-inferior to appendectomy in terms of health status at 30 days, with approximately 70% of patients avoiding surgery in the first year (PMID: 33017106). This trial provides robust evidence supporting antibiotics as an initial treatment option.

A systematic review and meta-analysis by Sallinen et al. (2016) found that while antibiotics can effectively treat uncomplicated appendicitis, about 27% of patients may require appendectomy within one year due to recurrence or treatment failure (PMID: 27590255). These findings highlight the need for careful patient selection and follow-up.

The APPAC trial (2015) also supports the use of antibiotics, showing that 73% of patients treated with antibiotics did not require surgery within a one-year follow-up period (PMID: 26080338). This trial remains influential in shaping current treatment paradigms.

Caveats and uncertainty

While antibiotics can effectively manage uncomplicated appendicitis, the risk of recurrence and the potential for complications, such as perforation, must be considered. Patients opting for antibiotic treatment require close monitoring and clear instructions on when to seek further medical attention.

The decision to use antibiotics should consider patient-specific factors, including age, comorbidities, and access to follow-up care. Further research is needed to identify predictors of treatment success and to refine criteria for patient selection.

How this may change practice

The evidence supporting antibiotics as an alternative to appendectomy may lead to more personalized treatment approaches for uncomplicated appendicitis. Clinicians should engage in shared decision-making with patients, discussing the potential benefits and risks of both treatment options.

Incorporating patient preferences and values into the decision-making process can enhance patient satisfaction and outcomes. Clinicians should remain informed about evolving evidence and guidelines to optimize care for patients with uncomplicated appendicitis.


References

  1. CODA Collaborative. A Randomized Trial Comparing Antibiotics with Appendectomy for Appendicitis. N Engl J Med 2020;383:1907-1919. PMID: 33017106 PMID: 33017106
  2. Sallinen V, et al. Meta-analysis of Antibiotics Versus Appendicectomy for Non-perforated Acute Appendicitis. Br J Surg 2016;103:656-667. PMID: 27590255 PMID: 27590255
  3. Salminen P, et al. Antibiotic Therapy vs Appendectomy for Treatment of Uncomplicated Acute Appendicitis: The APPAC Randomized Clinical Trial. JAMA 2015;313:2340-2348. PMID: 26080338 PMID: 26080338
  4. Note: This EvidenceDigest is for educational purposes only and should not be construed as medical advice.

© 2026 Ablatotech, Inc. All rights reserved. Reviewed by the Ablatotech Vitals editorial team